Isoplumbagin
Isoplumbagin is antimicrobial agent. Isoplumbagin exhibits anticancer activity mainly through modulating mitochondrial dynamics and function.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 14777-17-4
- Formule: C11H8O3
- Masse moléculaire:188.18
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform Antibiotic
More
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BT-549 | GI50 |
2.7 μM
Compound: 2
|
Antiproliferative activity against human BT-549 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human BT-549 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| CAL-51 | GI50 |
2.5 μM
Compound: 2
|
Antiproliferative activity against human CAL-51 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human CAL-51 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| HCC1954 | GI50 |
0.34 μM
Compound: 2
|
Antiproliferative activity against human HCC1954 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human HCC1954 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| HCT-116 | GI50 |
0.46 μM
Compound: 2
|
Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human HCT-116 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| K562 | GI50 |
1.3 μM
Compound: 2
|
Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human K562 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| MCF7 | GI50 |
1.4 μM
Compound: 2
|
Antiproliferative activity against human MCF7 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| MOLM-13 | GI50 |
4.1 μM
Compound: 2
|
Antiproliferative activity against human MOLM-13 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human MOLM-13 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| MV4-11 | GI50 |
26.5 μM
Compound: 2
|
Antiproliferative activity against human MV4-11 cells measured after 72 hrs by SRB assay
Antiproliferative activity against human MV4-11 cells measured after 72 hrs by SRB assay
|
[PMID: 35687347] |
| NCI-H1299 | IC50 |
1.5 μM
Compound: 143
|
Cytotoxicity against human NCI-H1299 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
Cytotoxicity against human NCI-H1299 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
|
[PMID: 38458106] |
| PC-3 | IC50 |
6 μM
Compound: 143
|
Cytotoxicity against human PC-3 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
Cytotoxicity against human PC-3 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
|
[PMID: 38458106] |
| U-87MG ATCC | IC50 |
2.4 μM
Compound: 143
|
Cytotoxicity against human U87 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
Cytotoxicity against human U87 cells incubated for 48 hrs by MTT reagent based spectrophotometric analysis
|
[PMID: 38458106] |
Chemical Information
-
CAS No. 14777-17-4
-
Masse moléculaire 188.18
-
Formule C11H8O3
-
SMILES
O=C1C(C)=CC(C2=C1C(O)=CC=C2)=O
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)